| pubmed-article:16870095 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16870095 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:16870095 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:16870095 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:16870095 | lifeskim:mentions | umls-concept:C0001807 | lld:lifeskim |
| pubmed-article:16870095 | lifeskim:mentions | umls-concept:C1138802 | lld:lifeskim |
| pubmed-article:16870095 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16870095 | pubmed:dateCreated | 2006-7-27 | lld:pubmed |
| pubmed-article:16870095 | pubmed:abstractText | To analyse the value of the anti-cyclic citrullinated peptide antibody (anti-CCP) in patients with rheumatoid arthritis (RA) as a prognostic factor, as well as its relationship with disease activity. | lld:pubmed |
| pubmed-article:16870095 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16870095 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16870095 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16870095 | pubmed:issn | 0392-856X | lld:pubmed |
| pubmed-article:16870095 | pubmed:author | pubmed-author:Loza... | lld:pubmed |
| pubmed-article:16870095 | pubmed:author | pubmed-author:del Val del... | lld:pubmed |
| pubmed-article:16870095 | pubmed:author | pubmed-author:Ibanez... | lld:pubmed |
| pubmed-article:16870095 | pubmed:author | pubmed-author:Fito... | lld:pubmed |
| pubmed-article:16870095 | pubmed:author | pubmed-author:Gutierrez... | lld:pubmed |
| pubmed-article:16870095 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16870095 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16870095 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16870095 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16870095 | pubmed:pagination | 281-6 | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:meshHeading | pubmed-meshheading:16870095... | lld:pubmed |
| pubmed-article:16870095 | pubmed:articleTitle | Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. | lld:pubmed |
| pubmed-article:16870095 | pubmed:affiliation | Rheumatology Department, Navarra Hospital, Pamplona, Spain. ndelvaldelamo@hotmail.com | lld:pubmed |
| pubmed-article:16870095 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16870095 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16870095 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16870095 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16870095 | lld:pubmed |
